周红潮;杜锐;王慧;曾范利;时坤;李建明;宗颖;
ZHOU Hong-chao;DU Rui;WANG Hui;ZENG Fan-li;SHI Kun;LI Jian-ming;ZONG Ying;College of Chinese Medicine Materials,Jilin Agricultural University;Key Laboratory of Animal Production,Product Quality and Security,Ministry of Education of the People's Republic of China,Laboratory of Production and Product Application of Sika Deer of Jilin Province;

• 1:吉林农业大学中药材学院
• 2:教育部动物生产及产品质量安全重点实验室吉林省梅花鹿生产与产品应用研究室

摘要(Abstract)：

黄芩是中国的传统中药材,其主产于河北、山东等地,具有解热、抗菌、抗炎、抗氧化等药理作用。黄芩苷是黄芩的主要活性成分,但是黄芩苷生物利用度低,制约了黄芩在临床上的使用。近年来,国内外对黄芩苷在体内代谢动态规律开展了大量研究,该文通过对黄芩苷及其复方药物中黄芩苷的药代动力学研究进展进行综述,并总结黄芩苷研究现状,旨在为黄芩苷进一步的研究提供科学依据。
Scutellariae baicalensis is one of the most important traditional Chinese medicinal herbs,mainly distributed in Shandong and Hebei provinces. It has significant pharmacological effects such as antimicrobial activity,anti-inflammatory and antioxidation. Baicalin is one of its main effective components. However,baicalin's low bioavailability has restricted its clinical application. In recent decades,extensive studies have been carried out on the metabolism of baicalin in vivo at home and abroad. In order to provide scientific references for baicalin's further studies,this paper would not only review the advances in pharmacokinetics research of baicalin and Chinese herbal preparations containing baicalin,but also make a summary on research status of baicalin.

关键词(KeyWords)： 黄芩苷;生物利用度;药代动力学;中药
baicalin;bioavailability;pharmacokinetics;traditional Chinese medicine

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年基金项目(31502109);; 吉林省科技厅科技支撑计划项目(20160209006YY);吉林省科技厅重点科技攻关项目(20150204028NY)

作者(Authors): 周红潮;杜锐;王慧;曾范利;时坤;李建明;宗颖;
ZHOU Hong-chao;DU Rui;WANG Hui;ZENG Fan-li;SHI Kun;LI Jian-ming;ZONG Ying;College of Chinese Medicine Materials,Jilin Agricultural University;Key Laboratory of Animal Production,Product Quality and Security,Ministry of Education of the People's Republic of China,Laboratory of Production and Product Application of Sika Deer of Jilin Province;

DOI: 10.19540/j.cnki.cjcmm.20171106.011

参考文献(References)：

• [1]Lin L T,Hsu W C,Lin C C.Antiviral natural products and herbal medicines[J].J Trad Complement Med,2014,4(1):24.
• [2]Thing Fong T,Shorong Shii L,I Min L.The selected traditional Chinese medicinal formulas for treating diabetic nephropathy:perspective of modern science[J].J Trad Complement Med,2013,3(3):152.
• [3]Gao Z,Xu H,Chen X,et al.Antioxidant status and mineral contents in tissues of rutin and baicalin fed rats[J].Life Sci,2003,73(12):1599.
• [4]Biswanath D,Subhajit D,Saikat D S,et al.Therapeutic potentials of baicalin and its aglycone,baicalein against inflammatory disorders[J].European J Med Chem,2017,131:68.
• [5]Wei F,Wang X,Zhang X Y.Application of graphene oxide as a catalyst to accelerate extraction of total flavonoids and the hydrolysis of baicalin from Radix Scutellaria[J].Sep Purif Tech,2014,133:421.
• [6]Zhao Q,Chen X Y,Martin C.Scutellaria baicalensis,the golden herb from the garden of Chinese medicinal plants[J].Sci Bull,2016,61(18):1391.
• [7]徐杨璐,赵胜男,刘素丽,等.液质联用法测定不同贮存期黄芩中6种黄酮类化合物含量[J].医药导报,2015,34(7):955.
• [8]Xu L,Li J,Zhang Y,et al.Regulatory effect of baicalin on the imbalance of Th17/Treg responses in mice with allergic asthma[J].J Ethnopharmacol,2017,7:1301.
• [9]Zhang Z,Jia P,Zhang X,et al.LC-MS/MS determination and pharmacokinetic study of seven flavonoids in rat plasma after oral administration of Cirsium japonicum DC.extract[J].J Ethnopharmacol,2014,158:66.
• [10]张伟,李耀华,梁臣艳.中药药代动力学研究进展[J].亚太传统医药,2015,11(14):37.
• [11]柏冬,王瑞海,刘丽梅.近十年中药药代动力学新技术新方法概述[J].环球中医药,2016,9(7):891.
• [12]陈凯丽,易剑锋,梁辉.中药复方药代动力学研究概况[J].宜春学院学报,2015,37(12):18.
• [13]余健,辛艳飞,宣尧仙.中药药代动力学研究进展[J].中华中医药学刊,2014(6):1337.
• [14]鲁一桐,孙博.黄芩苷药代动力学的研究进展[J].畜牧兽医科技信息,2014(8):14.
• [15]Medina J J M,Ferrer E G,Williams P A M,et al.Theoretical investigation of the conformational space of baicalin[J].J Mol Graph Mod,2017,76:181.
• [16]Xing J,Chen X,Zhong D.Absorption and enterohepatic circulation of baicalin in rats[J].Life Sci,2005,78(2):140.
• [17]Zhang J,Cai W,Zhou Y,et al.Profiling and identification of the metabolites of baicalin and study on their tissue distribution in rats by ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer[J].J Chromatogr B,2015,985:91.
• [18]杨迪,袁婷婷,干舒蕾,等.静脉注射黄芩苷、黄芩素在大鼠体内的药代规律比较研究[J].中国临床药理学与治疗学,2017,22(4):394.
• [19]Ma S W,Zhao M,Liu H X,et al.Pharmacokinetic effects of baicalin on cerebral ischemia-reperfusion after iv administration in rats[J].Chin Herb Med,2012,4(1):53.
• [20]龚明涛,虞丽芳,陈庆华,等.黄芩苷在大鼠体内的口服生物利用度屏障研究[J].中国药学杂志,2008,43(17):1332.
• [21]刘太明,蒋学华.黄芩苷和黄芩素大鼠在体胃、肠的吸收动力学研究[J].中国中药杂志,2006,31(12):999.
• [22]梁颖,王雷,王学艳,等.黄芩苷透皮给药系统的体内药代动力学研究[J].时珍国医国药,2012,23(8):1914.
• [23]Ran X,Liang Q,Luo G,et al.Simultaneous determination of geniposide,baicalin,cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatography-tandem mass spectrometry[J].J Chromatogr B Analyt Technol Biomed Life Sci,2006,842(1):22.
• [24]Fong S Y,Wong Y C,Zuo Z.Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein,wogonin,oroxylin A and their glucuronides baicalin,wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies[J].J Pharm Biomed Anal,2014,97:9.
• [25]Cai Y,Li S,Li T,et al.Oral pharmacokinetics of baicalin,wogonoside,oroxylin A 7-O-β-D-glucuronide and their aglycones from an aqueous extract of Scutellariae Radix in the rat[J].J Chromatogr B Analyt Technol Biomed Life Sci,2016,1026:124.
• [26]Yang Y F,Li Z,Xin W F,et al.Pharmacokinetics and brain distribution differences of baicalin in rat underlying the effect of panax notoginsenosides after intravenous administration[J].Chin J Nat Med,2014,12(8):632.
• [27]Xu B,Li P,Zhang G.Comparative pharmacokinetics of puerarin,daidzin,baicalin,glycyrrhizic acid,liquiritin,berberine,palmatine and jateorhizine by liquid chromatography-mass spectrometry after oral administration of gegenqinlian,decoction and active components alignm[J].J Chromatogr B Analyt Technol Biomed Life Sci,2015,988:33.
• [28]Huo X K,Wang B,Zheng L,et al.Comparative pharmacokinetic study of baicalin and its metabolites after oral administration of baicalin and Chaiqin Qingning capsule in normal and febrile rats[J].J Chromatogr B,2017,1059:14.
• [29]He M Y,Deng Y X,Shi Q Z,et al.Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction[J].J Ethnopharmacol,2014,155(1):334.
• [30]Zeng M F,Pan L M,Zhu H X,et al.Comparative pharmacokinetics of baicalin in plasma after oral administration of HuangLian-Jie-Du-Tang or pure baicalin in MCAO and sham-operated rats[J].Fitoterapia,2010,81(6):490.
• [31]Wei X Y,Tao J H,Cui X,et al.Comparative pharmacokinetics of six major bioactive components in normal and type 2 diabetic rats after oral administration of Sanhuang Xiexin decoction extracts by UPLC-TQ-MS/MS[J].J Chromatogr B,2017,doi:10.1016/j.jchromb.2017.07.026.
• [32]Huang T,Xiong Y,Chen N,et al.Highly selective enrichment of baicalin in rat plasma by boronic acid-functionalized core-shell magnetic microspheres:validation and application to a pharmacokinetic study[J].Talanta,2016,147:501.